Pancreatic Cancer Action Network
As Chief Science Officer, Lynn Matrisian brings extensive experience and passion for cancer research, combined with business training, to provide strategic direction for the scientific aspects of the initiatives and activities within the Scientific & Medical Affairs team toward the goal of improving outcomes for those facing pancreatic cancer.
Prior to joining the Pancreatic Cancer Action Network, Matrisian put her scientific training to work for 25 years leading a research laboratory dedicated to understanding cancer metastasis. She has published more than 250 original scientific articles and trained more than 30 young scientists who have gone on to join the fight against cancer in the academic, biotechnology, pharmaceutical, government and nonprofit sectors.
Matrisian was the founding chair of the department of cancer biology in the School of Medicine at Vanderbilt University, the president of the American Association for Cancer Research (AACR) and a special assistant to the director of the National Cancer Institute at the National Institutes of Health. She was elected to the AACR Academy, which recognizes and honors distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer.
Matrisian received a PhD in molecular biology from the University of Arizona and an MBA from the Owen Graduate School of Management at Vanderbilt University.
This person is not in any offices
Pancreatic Cancer Action Network
1 followers
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to dramatically improve patient outcomes.